Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide

NCT00044707 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00044707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00044707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2002
Completion date
September 30, 2002
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, non-insulin-dependent